Home Featured

Featured

Random

Illuminating the Hidden Self: Navigating the Jungian Shadow with Psychedelics

atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)

Levitee Labs Commences Trading in U.S. Under Ticker LVTTF

Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology

Nova Mentis Begins Enrollment in North American Autism Study

Red Light Holland Announces Closing of $11.6 Million Bought Deal Financing

Psyence Group and Pure Extracts Finalize “Pure Psyence,” A Joint Venture...

PT342 – Spencer Hawkswell – The Right to Psilocybin in Canada:...

Entheon Biomedical Corp. Provides Corporate Update

Gratitude Revealed: Film Screening and Q&A with Director Louie Schwartzberg

PT308 – Dr. Ido Cohen, PsyD – Vital Psychedelic Conversations

Terran Biosciences discovers what may be the first new salts, co-crystals,...

Five Important Events in Psychedelics History

Silo Wellness Partners with Mushe Inc. to Establish First Legal Brick...

Ayahuasca Chronicles: Exploring Amazonian Traditions and Nature Connectedness with Paloma David...

12 3...313 Page 1 of 313

EDITOR PICKS

Q1 2026 Psychedelic Patent Update

The Psychedelic Practitioner Issue 4: Integration

Shane Mauss – Comedy and Molecules – Episode 14

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.